ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: fatigue

Are We Making Progress in Treating Lupus? Clinical Insights from Dr. Michelle Petri

Jason Liebowitz, MD, FACR  |  November 1, 2023

At the 19th Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases course, Dr. Michelle Petri gave a presentation concerning the overall state of lupus treatment outcomes in the U.S.

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:glucocorticoidHydroxychloroquine (HCQ)

Get Your Patients Moving: Physical Activity Is Key for Pain Management & Overall Health

Vanessa Caceres  |  October 13, 2023

Regular movement is crucial for everyone, but patients with rheumatic disease may feel overwhelmed about starting and maintaining a routine. Here’s how physical and occupational therapists can help patients establish and reach movement goals, while improving their pain management and overall health.

Filed under:ConditionsPain Syndromes Tagged with:ACR on AirACR on Air podcastExercisePain Syndrome FocusRheumPhysical Therapy

Why Mental Health Screening Is Essential for Patients with Psoriatic Disease

Catherine Kolonko  |  October 12, 2023

Research suggests that patients with psoriasis and psoriatic arthritis (PsA) have a greater risk of depression, anxiety and, in some cases, substance abuse and dependence than the general population, yet symptoms often go unrecognized and untreated by medical professionals. Both psoriasis and PsA are associated with depression, with up to 30% of patients in either…

Filed under:ConditionsPsoriatic Arthritis Tagged with:Mental HealthPsA Resource Center

Rheumatologists Turn to Social Media to Educate Patients & Combat Misinformation

Linda Childers  |  October 12, 2023

When Taylor Warmoth, MD, a rheumatologist with Arthritis and Osteoporosis Associates (AOA), Lubbock, Texas, posted her first educational video on TikTok in 2022, she anticipated a moderate response. She was surprised when her medical assistant informed her the next day that her video had received over 5,000 views, 800 comments, and her account had gained…

Filed under:Practice SupportTechnology Tagged with:Social Media

Findings from a Clinical Trial of Dazodalibep for Sjögren’s Disease

Michele B. Kaufman, PharmD, BCGP  |  September 26, 2023

St.Clair et al. found that patients with Sjögren’s disease treated with dazodalibep experienced greater improvement in key symptoms of dryness, fatigue and pain than patients who received placebo.

Filed under:Biologics/DMARDsDrug UpdatesEULAR/OtherMeeting ReportsSjögren’s Disease Tagged with:EULAR 2023

Guideline for Integrative RA Interventions Released

Ruth Jessen Hickman, MD  |  August 3, 2023

Discussions between clinicians and their patients about complementary aspects of their care just got easier with the release of the 2022 ACR Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis.

Filed under:American College of RheumatologyClinical Criteria/GuidelinesConditionsGuidanceRheumatoid Arthritis Tagged with:RA Resource Center

Patient Education Materials for Non-English Speakers

Katie Robinson  |  July 10, 2023

Recently, the Vasculitis Foundation, in collaboration with a group of physicians and vasculitis investigators in the U.S. and Latin America (i.e., Mexico, Colombia, Peru, Chile and Argentina), launched an educational series of videos in Spanish called, Aprendiendo de Vasculitis. “The goal of these videos is to provide education to all Spanish-speaking patients,” explains Sebastian E….

Filed under:Patient PerspectivePractice Support Tagged with:health literacypatient education

Break the Barrier: Understanding & Treating Neuropsychiatric Lupus

Jason Liebowitz, MD, FACR  |  July 10, 2023

Updated research on the complexities of central nervous system (CNS) lupus, as well as its diagnosis and treatment are discussed.

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:ACR Education ExchangeACR Education Exchange 2023central nervous systemCNS lupusLupus

Mixed Results for Rezpegaldesleukin in Patients with Active SLE

Michele B. Kaufman, PharmD, BCGP  |  June 13, 2023

In a clinical trial, patients with active systemic lupus erythematosus (SLE) did not experience a reduction in disease activity with the addition of rezpegaldesleukin to their standard treatments. However, some patient populations did see improvements in their disease activity compared with the placebo-treated group.

Filed under:Drug UpdatesSystemic Lupus Erythematosus Tagged with:SLE Resource Center

RA Disease Activity & Alcohol Consumption Habits

Arthritis & Rheumatology  |  May 30, 2023

Past studies have suggested that patients with rheumatoid arthritis (RA) who consume a moderate amount of alcohol may experience lower disease activity and higher quality of life than non-drinkers. In this study, Alfredsson, et al. confirmed earlier studies’ claims that alcohol consumption reduces disease activity in a dose-dependent manner, and also indicated that patients who stopped drinking post-baseline experienced worsened disease activity, more pain and a lower quality of life.

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:AlcoholArthritis & RheumatologyDisease Activity Score (DAS)lifestylemoderate alcohol consumptionRA Resource CenterResearchRheumatoid Arthritis (RA)

  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 63
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences